“Mini-course: Micronucleos in vitro:\u00a0Applications and Challenges”. Dra.\u00a0Izabel Villela (Inn VITRO P&D, Brazil).<\/strong><\/p>\n

Free mini-course open to participants of 2nd Pan-American<\/p>\n

Local: Centro Brasileiro de Pesquisas F\u00edsicas (CBPF) – Audit\u00f3rio I – The course will be in Portuguese.<\/p>\n<\/td>\n<\/tr>\n

In vitro meeting – under invitation<\/strong><\/p>\n

Centro Brasileiro de Pesquisas F\u00edsicas (CBPF) – Audit\u00f3rio I<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n

\n 2nd Pan-American Conference for Alternative Methods, 2018<\/strong><\/span><\/p>\n THURSDAY, August 23rd<\/strong><\/span><\/p>\n<\/td>\n

\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n TIME<\/strong><\/span><\/td>\n \u00a0<\/td>\n<\/tr>\n \u00a0<\/td>\n Room 1 (180 seats)<\/strong><\/td>\n Room 2 (80 seats)<\/strong><\/td>\n<\/tr>\n 08:00<\/strong><\/td>\n Reception \/ Badge<\/strong><\/td>\n<\/tr>\n 08:40<\/strong><\/td>\n Opening Welcome<\/strong><\/td>\n<\/tr>\n 09:00<\/strong><\/td>\n \n Opening Ceremony – Thomas Hartung (CAAT – Johns Hopkins, USA)<\/strong><\/p>\n <\/i>\u00a0<\/span>Opening Ceremony_Thomas Hartung.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section I – Alternatives models for lung and skin.\u00a0Chair: Silvya Stuchi (USP).\u00a0<\/strong><\/td>\n Section II – Round Table – Humane Education encouragement policies in Latin America. Chair:\u00a0<\/span><\/b>R\u00f3ber Bachinski (1R Institute).<\/strong><\/td>\n<\/tr>\n 09:40<\/strong><\/td>\n \n 1. Pre-Validation of an Acute Inhalation Toxicity Assay Using the EpiAirway In Vitro Human Airway Model. Patrick Hayden (MatTek Corp).<\/p>\n <\/i>\u00a0<\/span>SECTION I_1_Patrick Hayden.pdf<\/a><\/p>\n<\/td>\n \n 1.\u00a0R\u00f3ber Bachinski (1R Institute).<\/p>\n <\/i>\u00a0<\/span>SECTION II_1_Rober Bachinski.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 10:00<\/strong><\/td>\n \n 2. A stochastic clonal selection for modeling intra tumor heterogeneity in human melanoma and clinical implications.\u00a0 Larissa A Carvalho (USP, SP).<\/p>\n<\/i>\u00a0SECTION I_2_Larissa A. Carvalho .pdf<\/a><\/p>\n<\/td>\n \n 2. Vanessa Bones (CRMV, PR – CONCEA Councillier).<\/p>\n <\/i>\u00a0<\/span>SECTION II_2_Vanessa Bones.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 10:20<\/strong><\/td>\n \n 3. Potential use of skin bioprinting on cosmetics. Juliana Lago (Natura).<\/p>\n<\/i>\u00a0SECTION I_3_Juliana Lago.pdf<\/a><\/p>\n<\/td>\n \n 3. Thales Tr\u00e9z (UNIFAL, MG).<\/p>\n  <\/p>\n<\/td>\n<\/tr>\n 10:40<\/strong><\/td>\n \n 4. Development of 3D bioprinted Reconstructed Skin models using native and non-native bioinks. Carolina Motter Catarino (Rensselaer Polytechnic Institute).\u00a0<\/p>\n<\/i>\u00a0SECTION I_4_Carolina Motter Catarino.pdf<\/a><\/p>\n<\/td>\n \n 4. Rita Leal Paix\u00e3o (UFF, RJ). \/ Replaced by Dr. Karynn Capil\u00e9.<\/p>\n <\/i>\u00a0<\/span>SECTION II_4_Karynn Capile.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 11:00<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section III – In silico and Computational Toxicology. Chair: Thomas Hartung.<\/strong><\/td>\n Section IV\u00a0 – Round Table – The development of new humane teaching methods. Chair: Nick Jukes (InterNiche).<\/strong><\/td>\n<\/tr>\n 11:30<\/strong><\/td>\n \n 1. A Defined Approach to Skin Sensitisation: Integrating Derek Nexus with In Chemico\/In Vitro Assays Based on Exclusion Criteria. Donna S. Macmillan (Lhasa Limited, Leeds, UK).<\/p>\n <\/i>\u00a0<\/span>SECTION III_1_Donna S. Macmillan.pdf<\/a><\/p>\n<\/td>\n \n 1. Nick Jukes (InterNICHE). (Replaced by R\u00f3ber Bachinski).<\/p>\n<\/td>\n<\/tr>\n 11:50<\/strong><\/td>\n \n 2. Challenges and opportunities for using AOP-based in silico models in regulatory contexts. Carlos Eduardo dos Santos, Altox.<\/p>\n <\/i>\u00a0<\/span>SECTION III_2_Carlos Eduardo dos Santos.pdf<\/a><\/p>\n<\/td>\n \n 2. Simone Tostes (UFPR, PR).<\/p>\n<\/td>\n<\/tr>\n 12:20<\/strong><\/td>\n \n 3. Best practices to develop artificial intelligence models for predicting multilevel effects in Adverse Outcome Pathways (AOP). Rodolpho C. Braga, Altox.<\/p>\n <\/i>\u00a0<\/span>SECTION III_3_Rodolpho C. Braga.pdf<\/a><\/p>\n<\/td>\n \n 3. Gutemberg Alves (UFF, RJ).<\/p>\n<\/td>\n<\/tr>\n 12:40<\/strong>\u00a0<\/td>\n \n 4. Modeling the Complex Relationships Between Chemical Properties, Adaptive Response, and Oxidative Stress. Fjodor Melnikov (Yale University, USA).<\/p>\n<\/td>\n \n 4.\u00a0 Maria Yanneth Torres Chaparro (UCC, Col\u00f4mbia).<\/p>\n <\/i>\u00a0<\/span>SECTION IV_4_Maria Yanneth Torres Chaparro.pdf<\/a><\/p>\n \n 5. Julia Maria Matera (USP, SP).<\/p>\n <\/i>\u00a0<\/span>SECTION IV_5_Julia Maria Matera.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n \u00a012:50<\/strong><\/td>\n \n 5. Green Toxicology: Using big data on little chemicals to guide safe design. Alexandra Maertens (CAAT, Johns Hopkins, USA).<\/p>\n <\/i>\u00a0<\/span>SECTION III_5_Alexandra Maertens.pdf<\/a><\/p>\n<\/td>\n \n 6. Myocutaneous simulator for teaching suture and reconstructive surgery. Matheus Cruz (UFPR, PR).<\/p>\n<\/td>\n<\/tr>\n 13:00<\/strong><\/td>\n Lunch<\/strong><\/td>\n Lunch<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section V – Cosmetics and Fragrances: Progress and Challenges for the Future. Chair: Vanessa Rocha (Natura, SP).<\/strong><\/td>\n Section VI – Animal protection and science advance. Chair: Norma Labarthe (FIOCRUZ, Brasil).<\/strong><\/td>\n<\/tr>\n 14:10<\/strong><\/td>\n \n 1. Safety assessment of cosmetics\u00a0with no animal testing. Vanessa Rocha (Natura).<\/p>\n <\/i>\u00a0<\/span>SECTION V_1_Vanessa Rocha.pdf<\/a><\/p>\n<\/td>\n \n 1. Advancing Science Without Suffering in Brazil.\u00a0<\/span>Helder Constantino (Humane Society International, Brazil).<\/p>\n <\/i>\u00a0<\/span>SECTION VI_1_Helder Constantino.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 14:30<\/strong><\/td>\n \n 2. Intensifying alternative methods for the application in the development of cosmetic projects. Marcio Lorencini (Botic\u00e1rio, PR).<\/p>\n <\/i>\u00a0<\/span>SECTION V_2_Marcio Lorencini.pdf<\/a><\/p>\n<\/td>\n \n 2. A new definition for animal-free testing. Replacing animal-derived components in regulatory in vitro methods.\u00a0<\/span>Carol Treasure (XCellR8, USA).<\/p>\n <\/i>\u00a0<\/span>SECTION VI_2_Carol Treasure.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 14:50<\/strong><\/td>\n 3. Implementation, availability and regulatory status of an OECD accepted Reconstructed Human Epidermis model in Brazil.\u00a0 Rodrigo De Vecchi (L’OREAL, RJ).<\/td>\n \n 3. Implementation needs on alternative methods in Brasil: An animal protection perspective.\u00a0<\/span>Norma Labarthe (FIOCRUZ, RJ).<\/p>\n <\/i>\u00a0<\/span>SECTION VI_3_Norma Labarthe.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 15:10<\/strong><\/td>\n \n 4. How the fragrance industry engages in alternatives for animal testing. Matthias Vey (IFRA, (IFRA, Belgium).<\/p>\n <\/i>\u00a0<\/span>SECTION V_4_Matthias Vey.pdf<\/a><\/p>\n<\/td>\n 4. Round table and open microphone.<\/td>\n<\/tr>\n 15:30<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section VII – Mini brains, Sensory Neurons and applications. Chair: Stevens Kastrup Rehen – UFRJ.<\/strong><\/td>\n Section VIII – Legislation and Validation Centers. Chair: Jos\u00e9 Mauro Granjeiro (INMETRO\/UFF) and Charu Chandrasekera (Canadian Center of Alternative Methods).<\/strong>\u00a0<\/td>\n<\/tr>\n 16:00<\/strong><\/td>\n \n 1. New insights about brain development using stem cells and organoids.\u00a0 Stevens Rehen. (UFRJ\/IDOR, RJ).<\/p>\n<\/td>\n \n 1.CONCEA Normatives and perspectives for 2019 and 2021 deadlines. Monica Andersen\u00a0(CONCEA).<\/p>\n<\/i>\u00a0SECTION VIII_1_Monica Andersen.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 16:20<\/strong><\/td>\n \n 2. The application of Brain organoids to investigate CNS diseases and test drugs. Patr\u00edcia Braga (USP,SP).<\/p>\n<\/i>\u00a0SECTION VII_2_Patricia Braga.pdf<\/a><\/p>\n<\/td>\n \n 2. Contribution of BRACVAM and Validations on going. Octavio Presgrave (INCQS, RJ).<\/p>\n<\/i>\u00a0SECTION VIII_2_Octavio Presgrave.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 16:40<\/strong><\/td>\n \n 3. Potential applications of hiPSC-derived Peripheral Sensory Neurons in vitro models. Marilia P. Guimar\u00e3es Zaluar (UFRJ\/IDOR).<\/p>\n<\/i>\u00a0SECTION VII_3_Marilia Zaluar Guimaraes.pdf<\/a><\/p>\n<\/td>\n 3. New Canadian Centre for Alternatives: Vision & Strategy. (CCAAM). Charu Chandrasekera. (CCAM, Canada).<\/td>\n<\/tr>\n 17:00<\/strong><\/td>\n \n 4. A high content screening platform to evaluate viral infection in human brain cells. Karina Karmirian (iDor).<\/p>\n<\/i>\u00a0SECTION VII_4_Karina Karmirian.pdf<\/a><\/p>\n<\/td>\n \n 4. Round table and open Microphone.<\/p>\n<\/i>\u00a0\u00a0SECTION VIII_CHAIR VII_Jose Mauro Granjeiro.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 17:20<\/strong><\/td>\n Plenary Lecture Jose Granjeiro (INMETRO, RJ)<\/strong><\/td>\n<\/tr>\n 18:00<\/strong><\/td>\n Get Together<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n  <\/p>\n  <\/p>\n\n\n\n \n 2nd Pan-American Conference for Alternative Methods, 2018<\/strong><\/span><\/p>\n FRIDAY, August 24th<\/strong><\/span><\/p>\n<\/td>\n \u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n TIME<\/strong><\/span><\/td>\n \u00a0<\/td>\n<\/tr>\n \u00a0<\/td>\n Room 1 (180 seats)<\/strong><\/td>\n Room 2 (80 seats)<\/strong><\/td>\n<\/tr>\n 09:00<\/strong><\/td>\n Plenary Lecture\u00a0 Vanessa Rocha (Natura, Brazil)<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section IX – Human on a chip technology – Chair: Talita Marin (LNBIO, SP).<\/strong><\/td>\n Section X – 3D\u00a0Tissue Equivalents: Skin and Eye.\u00a0Chair: Thomas Hartung.<\/strong><\/td>\n<\/tr>\n 09:40<\/strong><\/td>\n \n 1. Human on a Chip Systems as a Better Alternative to Determining Toxicity and Efficacy of Compounds Than Animal – James J. Hickman (University of Central Florida).<\/p>\n<\/td>\n \n 1. Interlaboratory comparison of OECD TG 439 in Brazil. Luciene Ballotin (INMETRO).<\/p>\n<\/i>\u00a0SECTION X_1_Luciene Ballotin.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 10:00<\/strong><\/td>\n \n 2. Human on a chip plataform for sensitizer. Eduardo Pagani (CNPEN\/LNBIO, SP).<\/p>\n<\/td>\n \n 2. Animal-free safety assessment for children\u00b4s articles: the first successful implementation of Reconstructed Human Epidermis (RhE) model as an in vitro test for regulatory purposes in Brazil, Fabiana Medeiros (Biosintesis Laboratory).<\/p>\n<\/i>\u00a0SECTION X_2_Fabiana Medeiros.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 10:20<\/strong><\/td>\n \n 3. Microphysiological Systems (MPS): principles and applications to health science research. Talita M Marin (CNPEM\/LNBio).<\/p>\n<\/i>\u00a0SECTION IX_3_Talita Miguel Marin.pdf<\/a><\/p>\n<\/td>\n \n 3. EpiOcular Eye Irritation Test (EpiOcular-EIT) for identification of materials not requiring classification and labeling for eye irritation or serious eye damage. Patrick Hayden (Mattek, USA).<\/p>\n<\/i>\u00a0SECTION X_3_Patrick Hayden.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 10:40<\/strong><\/td>\n \n 4.\u00a0 Implementation of human models on a chip: challenges and solutions. Margaret Magdesian (Ananda Devices,Canada).\u00a0<\/p>\n<\/i>\u00a0SECTION IX_4_Margaret Magdesian.pdf<\/a><\/p>\n<\/td>\n \n 4. Corneal epithelium biomimetic model for eye toxicity testing to support innovation in Brazil. Artur CG da Silva (UFGO, GO).<\/p>\n<\/i>\u00a0SECTION X_4_Artur CG da Silva.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 11:00<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section XI –\u00a0 Skin Sensitization: Are we ready for replacement? Chair: Marize Campos (UFG, GO).<\/strong><\/td>\n Section XII – Vaccines: Making difference on reduction. Patr\u00edcia dos Santos Carneiro (Instituto Butantan , SP).<\/strong><\/td>\n<\/tr>\n 11:30<\/strong><\/td>\n \n 1. Implementation and Validation of Keratinosens, DPRA and HCLAT, Brazilian experience. Marize Campos (UFG, GO).<\/p>\n<\/i>\u00a0SECTION XI_Chair XI_Marize Campos.pdf<\/a><\/p>\n<\/td>\n \n 1. Alternative methods insertion into the QC lab routine: status and challenges. Patr\u00edcia dos Santos Carneiro (Instituto Butantan , SP).\u00a0<\/p>\n<\/i>\u00a0SECTION XII_CHAIR XII_Patricia dos Santos Carneiro .pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 11:50<\/strong><\/td>\n \n 2. The GARD assay for skin sensitization testing \u2013 validation, predictive performance and applicability for cosmetic ingredients. Andy Forreryd (Senzagen, Sweden).<\/p>\n<\/i>\u00a0SECTION XI_2_Andy Forreryd.pdf<\/a><\/p>\n<\/td>\n 2. Safety tests: MAT for Yellow-fever and meningococcal vaccines. Alessandra Santos Almeida (Biomanguinhos\/Fiocruz, RJ).<\/td>\n<\/tr>\n 12:10<\/strong><\/td>\n 3. U-SENS, and OECD method, considered in a Non-Animal approach for predicting skin sensitization. Nathalie Al\u00e9p\u00e9e (L\u00b4Or\u00e9al Research and Innovation, France).<\/td>\n \n 3. In vitro alternatives for the in vivo rabies vaccine potency. Wlamir Correa de Moura (INCQS, RJ).\u00a0<\/p>\n<\/i>\u00a0SECTION XII_3_Wlamir Correa de Moura.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 12:30<\/strong><\/td>\n \n 4. Assessment of skin sensitizing potential of UV-filters by a novel in vitro method based on DPRA. Lorena Rigo Gaspar (USP, SP).\u00a0<\/p>\n<\/i>\u00a0SECTION XI_4_Lorena Rigo Gaspar.pdf<\/a><\/p>\n<\/td>\n \n 4. Validation of an in vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines. Beatriz Lourenco Correia Moreira (Instituto de Tecnologia do Paran\u00e1 \u2013 TECPAR, PR).<\/p>\n<\/i>\u00a0SECTION XII_4_Beatriz Lourenco Correia Moreira.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 12:50\u00a0<\/strong><\/td>\n \n 5. Use of the Caenorhabditis elegans as an alternative model for evaluating the allergen potential of skin sensitisers. Camila Braggion (UNIFESP, SP).<\/p>\n<\/i>\u00a0SECTION XI_5_Camila Braggion.pdf<\/a><\/p>\n<\/td>\n \n 5. Butantan experience on the in vitro alternatives for hyperimmune sera analysis: safety and potency tests. Eliana Blini Marengo (Instituto Butantan,SP).<\/p>\n<\/i>\u00a0SECTION XII_5_Eliana Blini Marengo.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 13:10<\/strong><\/td>\n Lunch<\/strong><\/td>\n Lunch<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section XIII – Agrochemicals – Alternative Methods Approach\u00a0 Chair: Karen Cazarin (BASF).<\/strong><\/td>\n Section XIV – New strategies for Efficacy and Safety in Cosmetics.\u00a0<\/span>Jos\u00e9 Mauro Granjeiro (INMETRO, RJ).<\/strong><\/td>\n<\/tr>\n 14:10<\/strong><\/td>\n \n 1. US\/Canada approach on alternative method. Angela Hofstra (Syngenta, USA).<\/p>\n<\/i>\u00a0SECTION XIII_1_Angela Hofstra.pdf<\/a><\/p>\n<\/td>\n \n 1. Human organotypic skin explant culture (hosec): an alternative method for tropical diseases and cosmetic.\u00a0<\/span>Marco Andrey Cipriani Frade (HCFMRP-USP).<\/p>\n<\/i>\u00a0SECTION XIV_1_Marco Andrey Cipriani Frade.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 14:20<\/strong><\/td>\n \n 2. Industry approach on alternative methods- Andef Task Force – Andreia Latorre (Bayer Cropscience).<\/p>\n<\/i>\u00a0SECTION XIII_2_Andreia Latorre.pdf<\/a><\/p>\n<\/td>\n \n 2. Gene expression screening to identify activation profiles in skin after exposition to cosmetic ingredients.\u00a0<\/span>Daniela Zimbardi (Natura, SP).<\/p>\n<\/i>\u00a0SECTION XIV_2_Daniela Zimbardi.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 14:30<\/strong><\/td>\n \n 3. Skin irritation studies for agrochemicals registration: Comparison of in vitro and in vivo results. Diogo Zoltay Alvez (M\u00e9rieux NutriScience \/ Bioagri Laborat\u00f3rios).\u00a0<\/p>\n<\/i>\u00a0SECTION XIII_3_Diogo Zoltay Alves.pdf<\/a><\/p>\n<\/td>\n \n 3. Ex vivo skin model: an alternative tool for efficacy assessment.\u00a0<\/span>Michelle Sabrina da Silva (Kosmoscience Group).<\/p>\n<\/i>\u00a0SECTION XIV_3_Michelle Sabrina.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 14:50<\/strong><\/td>\n \n 4. Open Microphone.<\/p>\n<\/td>\n \n 4. An Integrated Testing Strategy for in vitro Skin Corrosion and Irritation Assessment using SkinEthic Reconstructed Human Epidermis.<\/span>Nathalie Alepee (L’OREAL, France).<\/p>\n<\/i>\u00a0SECTION XIV_4_Nathalie Alepee.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 15:30<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n coffee and poster session<\/strong><\/td>\n<\/tr>\n \u00a0<\/strong><\/td>\n Section XV –\u00a0 Section XV – Alternative Methods initiatives in South America. Chair: Luciene Ballotin (INMETRO, RJ).<\/b><\/strong><\/td>\n Section XVI – Other perspectives for Alternatives. Chair: Humberto de Mello Brand\u00e3o (Empraba, MG).<\/strong><\/td>\n<\/tr>\n 16:00<\/strong><\/td>\n \n 1.\u00a0\u00a0Premasur, the MERCOSUR’s Platform for Alternative Methods. Luciene Ballotin (INMETRO).<\/p>\n<\/i>\u00a0SECTION XV_1_Luciene Ballotin.pdf<\/a><\/p>\n<\/td>\n 1. Hydra, a freshwater cnidarian, offers great potential as an alternative model organism for chemical risk assessment. Mohammad A. Akbarsha (Bharathidasan University, India).<\/td>\n<\/tr>\n 16:20<\/strong><\/td>\n \n 2. Alternative methods in Argentina: regulation, legislation and capacities for the incorporation of new methodologies. Maria Laura Gutierrez (Institute of Pharmacology, University of Buenos Aires).<\/p>\n<\/i>\u00a0SECTION XV_2_Maria Laura Gutierrez.pdf<\/a><\/p>\n<\/td>\n \n 2. Novel strategies for 3D cell culture & developmental tissue engineering. Leandra Baptista (INMETRO-UFRJ).<\/p>\n<\/i>\u00a0SECTION XVI_2_Leandra Baptista.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 16:40<\/strong><\/td>\n \n 3. Development of national capacities for the implementation of alternative methods: a new challenge in Uruguay. Mariela Bollati-Fogol\u00edn. Institut Paster de Montevideo.<\/p>\n<\/i>\u00a0SECTION XV_3_Mariela Bollati-Fogolin.pdf<\/a><\/p>\n<\/td>\n \n 3. New opacitometer for eye irritation to (OECD GT 437). Humberto de Mello Brand\u00e3o (Empraba, MG).<\/p>\n<\/i>\u00a0SECTION XVI_3_Humberto de Mello Brandao.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 17:00<\/strong><\/td>\n \n 4. Get 2 for 1: A dual reporter cell line for simultaneous detection of substances with estrogenic and\/or androgenic activity. Romina Pagotto. Institut Pasteur de Montevideo.<\/p>\n<\/i>\u00a0SECTION XV_4_Romina Pagotto.pdf<\/a><\/p>\n<\/td>\n \n 4. Zebrafish early-life stage as a refinement to predict acute oral toxicity. Lara Barroso Brito (UFG, Brazil).<\/p>\n<\/i>\u00a0SECTION XVI_4_Lara Barroso Brito.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n 17:20<\/strong><\/td>\n Plenary Lecture Charu Chandrasekera (Canadian Centre for Alternatives to Animal Methods, Canada)<\/strong><\/td>\n<\/tr>\n 18:00<\/strong><\/td>\n Closing Ceremony – Poster Premium<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Video Lectures Salon Guanabara [wonderplugin_slider id=3]     Salon\u00a0Plaza [wonderplugin_slider id=4]     Oral Presentation Oral Presentation Guidelines Accepted abstracts for Oral and Poster Presentation – 2018 – July – 20th Poster Presentation Poster Preparation Guidelines \u00a0Accepted abstracts for Poster Presentation – 2018 – July – 20th   2nd Pan-American Conference for Alternative Methods, 2018 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"_joinchat":[],"footnotes":""},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"SBM","author_link":"https:\/\/metrologia.org.br\/wpsite\/author\/root\/"},"rttpg_comment":0,"rttpg_category":null,"rttpg_excerpt":"Video Lectures Salon Guanabara [wonderplugin_slider id=3]     Salon\u00a0Plaza [wonderplugin_slider id=4]     Oral Presentation Oral Presentation Guidelines Accepted abstracts for Oral and Poster Presentation – 2018 – July – 20th Poster Presentation Poster Preparation Guidelines \u00a0Accepted abstracts for Poster Presentation – 2018 – July – 20th   2nd Pan-American Conference for Alternative Methods, 2018…","_links":{"self":[{"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/pages\/3829"}],"collection":[{"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/comments?post=3829"}],"version-history":[{"count":117,"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/pages\/3829\/revisions"}],"predecessor-version":[{"id":4481,"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/pages\/3829\/revisions\/4481"}],"wp:attachment":[{"href":"https:\/\/metrologia.org.br\/wpsite\/wp-json\/wp\/v2\/media?parent=3829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}